img

Global 2-valent HPV Vaccine (2vHPV) Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global 2-valent HPV Vaccine (2vHPV) Market Insights, Forecast to 2034

A vaccine that can prevent HPV infection and prevent subsequent HPV-related diseases
Global 2-valent HPV Vaccine (2vHPV) market is expected to reach to US$ 4130 million in 2024, with a positive growth of %, compared with US$ 3870 million in 2022. Backed with the increasing demand from downstream industries, 2-valent HPV Vaccine (2vHPV) industry is evaluated to reach US$ 6128.8 million in 2029. The CAGR will be 6.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global 2-valent HPV Vaccine (2vHPV) market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global 2-valent HPV Vaccine (2vHPV) market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
MSD
Beijing Wantai Biology Pharmaceutical Industry Limited
Serum Institute of India
Walvax
Segment by Type
HPV16
HPV18

Segment by Application


9-16 Years Old
16-20 Years Old
20-26 Years Old
26-45 Years Old

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ 2-valent HPV Vaccine (2vHPV) plant distribution, commercial date of 2-valent HPV Vaccine (2vHPV), product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, 2-valent HPV Vaccine (2vHPV) introduction, etc. 2-valent HPV Vaccine (2vHPV) Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of 2-valent HPV Vaccine (2vHPV)
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 2-valent HPV Vaccine (2vHPV) Product Introduction
1.2 Market by Type
1.2.1 Global 2-valent HPV Vaccine (2vHPV) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 HPV16
1.2.3 HPV18
1.3 Market by Application
1.3.1 Global 2-valent HPV Vaccine (2vHPV) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 9-16 Years Old
1.3.3 16-20 Years Old
1.3.4 20-26 Years Old
1.3.5 26-45 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 2-valent HPV Vaccine (2vHPV) Sales Estimates and Forecasts 2018-2029
2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region
2.2.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2018-2024)
2.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2024-2029)
2.2.4 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2018-2029)
2.3 Global 2-valent HPV Vaccine (2vHPV) Sales Estimates and Forecasts 2018-2029
2.4 Global 2-valent HPV Vaccine (2vHPV) Sales by Region
2.4.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2018-2024)
2.4.3 Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2024-2029)
2.4.4 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Manufacturers
3.1.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Manufacturers (2018-2024)
3.1.2 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 2-valent HPV Vaccine (2vHPV) in 2022
3.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Manufacturers
3.2.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Manufacturers (2018-2024)
3.2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by 2-valent HPV Vaccine (2vHPV) Revenue in 2022
3.3 Global Key Players of 2-valent HPV Vaccine (2vHPV), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global 2-valent HPV Vaccine (2vHPV) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global 2-valent HPV Vaccine (2vHPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Product Offered and Application
3.8 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Type
4.1.1 Global 2-valent HPV Vaccine (2vHPV) Historical Sales by Type (2018-2024)
4.1.2 Global 2-valent HPV Vaccine (2vHPV) Forecasted Sales by Type (2024-2029)
4.1.3 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
4.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type
4.2.1 Global 2-valent HPV Vaccine (2vHPV) Historical Revenue by Type (2018-2024)
4.2.2 Global 2-valent HPV Vaccine (2vHPV) Forecasted Revenue by Type (2024-2029)
4.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
4.3 Global 2-valent HPV Vaccine (2vHPV) Price by Type
4.3.1 Global 2-valent HPV Vaccine (2vHPV) Price by Type (2018-2024)
4.3.2 Global 2-valent HPV Vaccine (2vHPV) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Application
5.1.1 Global 2-valent HPV Vaccine (2vHPV) Historical Sales by Application (2018-2024)
5.1.2 Global 2-valent HPV Vaccine (2vHPV) Forecasted Sales by Application (2024-2029)
5.1.3 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
5.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application
5.2.1 Global 2-valent HPV Vaccine (2vHPV) Historical Revenue by Application (2018-2024)
5.2.2 Global 2-valent HPV Vaccine (2vHPV) Forecasted Revenue by Application (2024-2029)
5.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
5.3 Global 2-valent HPV Vaccine (2vHPV) Price by Application
5.3.1 Global 2-valent HPV Vaccine (2vHPV) Price by Application (2018-2024)
5.3.2 Global 2-valent HPV Vaccine (2vHPV) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada 2-valent HPV Vaccine (2vHPV) Market Size by Type
6.1.1 US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2029)
6.1.2 US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2029)
6.2 US & Canada 2-valent HPV Vaccine (2vHPV) Market Size by Application
6.2.1 US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2029)
6.2.2 US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2029)
6.3 US & Canada 2-valent HPV Vaccine (2vHPV) Market Size by Country
6.3.1 US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Country (2018-2029)
6.3.3 US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe 2-valent HPV Vaccine (2vHPV) Market Size by Type
7.1.1 Europe 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2029)
7.1.2 Europe 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2029)
7.2 Europe 2-valent HPV Vaccine (2vHPV) Market Size by Application
7.2.1 Europe 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2029)
7.2.2 Europe 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2029)
7.3 Europe 2-valent HPV Vaccine (2vHPV) Market Size by Country
7.3.1 Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2018-2029)
7.3.3 Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China 2-valent HPV Vaccine (2vHPV) Market Size
8.1.1 China 2-valent HPV Vaccine (2vHPV) Sales (2018-2029)
8.1.2 China 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029)
8.2 China 2-valent HPV Vaccine (2vHPV) Market Size by Application
8.2.1 China 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2029)
8.2.2 China 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia 2-valent HPV Vaccine (2vHPV) Market Size by Type
9.1.1 Asia 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2029)
9.1.2 Asia 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2029)
9.2 Asia 2-valent HPV Vaccine (2vHPV) Market Size by Application
9.2.1 Asia 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2029)
9.2.2 Asia 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2029)
9.3 Asia 2-valent HPV Vaccine (2vHPV) Sales by Region
9.3.1 Asia 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia 2-valent HPV Vaccine (2vHPV) Revenue by Region (2018-2029)
9.3.3 Asia 2-valent HPV Vaccine (2vHPV) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Market Size by Type
10.1.1 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Market Size by Application
10.2.1 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country
10.3.1 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK 2-valent HPV Vaccine (2vHPV) Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 MSD
11.2.1 MSD Company Information
11.2.2 MSD Overview
11.2.3 MSD 2-valent HPV Vaccine (2vHPV) Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 MSD 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MSD Recent Developments
11.3 Beijing Wantai Biology Pharmaceutical Industry Limited
11.3.1 Beijing Wantai Biology Pharmaceutical Industry Limited Company Information
11.3.2 Beijing Wantai Biology Pharmaceutical Industry Limited Overview
11.3.3 Beijing Wantai Biology Pharmaceutical Industry Limited 2-valent HPV Vaccine (2vHPV) Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Beijing Wantai Biology Pharmaceutical Industry Limited 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Beijing Wantai Biology Pharmaceutical Industry Limited Recent Developments
11.4 Serum Institute of India
11.4.1 Serum Institute of India Company Information
11.4.2 Serum Institute of India Overview
11.4.3 Serum Institute of India 2-valent HPV Vaccine (2vHPV) Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Serum Institute of India 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute of India Recent Developments
11.5 Walvax
11.5.1 Walvax Company Information
11.5.2 Walvax Overview
11.5.3 Walvax 2-valent HPV Vaccine (2vHPV) Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Walvax 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 2-valent HPV Vaccine (2vHPV) Industry Chain Analysis
12.2 2-valent HPV Vaccine (2vHPV) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 2-valent HPV Vaccine (2vHPV) Production Mode & Process
12.4 2-valent HPV Vaccine (2vHPV) Sales and Marketing
12.4.1 2-valent HPV Vaccine (2vHPV) Sales Channels
12.4.2 2-valent HPV Vaccine (2vHPV) Distributors
12.5 2-valent HPV Vaccine (2vHPV) Customers
13 Market Dynamics
13.1 2-valent HPV Vaccine (2vHPV) Industry Trends
13.2 2-valent HPV Vaccine (2vHPV) Market Drivers
13.3 2-valent HPV Vaccine (2vHPV) Market Challenges
13.4 2-valent HPV Vaccine (2vHPV) Market Restraints
14 Key Findings in The Global 2-valent HPV Vaccine (2vHPV) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global 2-valent HPV Vaccine (2vHPV) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of HPV16
Table 3. Major Manufacturers of HPV18
Table 4. Global 2-valent HPV Vaccine (2vHPV) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global 2-valent HPV Vaccine (2vHPV) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2018-2024)
Table 9. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2024-2029)
Table 10. Global 2-valent HPV Vaccine (2vHPV) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2018-2024) & (K Units)
Table 12. Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2024-2029) & (K Units)
Table 13. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2018-2024)
Table 14. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2024-2029)
Table 15. Global 2-valent HPV Vaccine (2vHPV) Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global 2-valent HPV Vaccine (2vHPV) Sales Share by Manufacturers (2018-2024)
Table 17. Global 2-valent HPV Vaccine (2vHPV) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of 2-valent HPV Vaccine (2vHPV), Industry Ranking, 2021 VS 2022 VS 2024
Table 20. 2-valent HPV Vaccine (2vHPV) Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global 2-valent HPV Vaccine (2vHPV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global 2-valent HPV Vaccine (2vHPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 2-valent HPV Vaccine (2vHPV) as of 2022)
Table 23. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Product Offered and Application
Table 25. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2024) & (K Units)
Table 28. Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2024-2029) & (K Units)
Table 29. Global 2-valent HPV Vaccine (2vHPV) Sales Share by Type (2018-2024)
Table 30. Global 2-valent HPV Vaccine (2vHPV) Sales Share by Type (2024-2029)
Table 31. Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Type (2018-2024)
Table 34. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Type (2024-2029)
Table 35. 2-valent HPV Vaccine (2vHPV) Price by Type (2018-2024) & (US$/Unit)
Table 36. Global 2-valent HPV Vaccine (2vHPV) Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2024) & (K Units)
Table 38. Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2024-2029) & (K Units)
Table 39. Global 2-valent HPV Vaccine (2vHPV) Sales Share by Application (2018-2024)
Table 40. Global 2-valent HPV Vaccine (2vHPV) Sales Share by Application (2024-2029)
Table 41. Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Application (2018-2024)
Table 44. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Application (2024-2029)
Table 45. 2-valent HPV Vaccine (2vHPV) Price by Application (2018-2024) & (US$/Unit)
Table 46. Global 2-valent HPV Vaccine (2vHPV) Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada 2-valent HPV Vaccine (2vHPV) Sales by Country (2024-2029) & (K Units)
Table 60. Europe 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2024) & (K Units)
Table 61. Europe 2-valent HPV Vaccine (2vHPV) Sales by Type (2024-2029) & (K Units)
Table 62. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2024) & (K Units)
Table 65. Europe 2-valent HPV Vaccine (2vHPV) Sales by Application (2024-2029) & (K Units)
Table 66. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe 2-valent HPV Vaccine (2vHPV) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2018-2024) & (K Units)
Table 72. Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2024-2029) & (K Units)
Table 73. China 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2024) & (K Units)
Table 74. China 2-valent HPV Vaccine (2vHPV) Sales by Type (2024-2029) & (K Units)
Table 75. China 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2024) & (US$ Million)
Table 76. China 2-valent HPV Vaccine (2vHPV) Revenue by Type (2024-2029) & (US$ Million)
Table 77. China 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2024) & (K Units)
Table 78. China 2-valent HPV Vaccine (2vHPV) Sales by Application (2024-2029) & (K Units)
Table 79. China 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2024) & (US$ Million)
Table 80. China 2-valent HPV Vaccine (2vHPV) Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2024) & (K Units)
Table 82. Asia 2-valent HPV Vaccine (2vHPV) Sales by Type (2024-2029) & (K Units)
Table 83. Asia 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia 2-valent HPV Vaccine (2vHPV) Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2024) & (K Units)
Table 86. Asia 2-valent HPV Vaccine (2vHPV) Sales by Application (2024-2029) & (K Units)
Table 87. Asia 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia 2-valent HPV Vaccine (2vHPV) Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia 2-valent HPV Vaccine (2vHPV) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia 2-valent HPV Vaccine (2vHPV) Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia 2-valent HPV Vaccine (2vHPV) Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia 2-valent HPV Vaccine (2vHPV) Sales by Region (2018-2024) & (K Units)
Table 93. Asia 2-valent HPV Vaccine (2vHPV) Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2024-2029) & (K Units)
Table 107. GSK Company Information
Table 108. GSK Description and Major Businesses
Table 109. GSK 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. GSK 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GSK Recent Developments
Table 112. MSD Company Information
Table 113. MSD Description and Major Businesses
Table 114. MSD 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. MSD 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. MSD Recent Developments
Table 117. Beijing Wantai Biology Pharmaceutical Industry Limited Company Information
Table 118. Beijing Wantai Biology Pharmaceutical Industry Limited Description and Major Businesses
Table 119. Beijing Wantai Biology Pharmaceutical Industry Limited 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Beijing Wantai Biology Pharmaceutical Industry Limited 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Beijing Wantai Biology Pharmaceutical Industry Limited Recent Developments
Table 122. Serum Institute of India Company Information
Table 123. Serum Institute of India Description and Major Businesses
Table 124. Serum Institute of India 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Serum Institute of India 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Serum Institute of India Recent Developments
Table 127. Walvax Company Information
Table 128. Walvax Description and Major Businesses
Table 129. Walvax 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Walvax 2-valent HPV Vaccine (2vHPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Walvax Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. 2-valent HPV Vaccine (2vHPV) Distributors List
Table 135. 2-valent HPV Vaccine (2vHPV) Customers List
Table 136. 2-valent HPV Vaccine (2vHPV) Market Trends
Table 137. 2-valent HPV Vaccine (2vHPV) Market Drivers
Table 138. 2-valent HPV Vaccine (2vHPV) Market Challenges
Table 139. 2-valent HPV Vaccine (2vHPV) Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. 2-valent HPV Vaccine (2vHPV) Product Picture
Figure 2. Global 2-valent HPV Vaccine (2vHPV) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global 2-valent HPV Vaccine (2vHPV) Market Share by Type in 2022 & 2029
Figure 4. HPV16 Product Picture
Figure 5. HPV18 Product Picture
Figure 6. Global 2-valent HPV Vaccine (2vHPV) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global 2-valent HPV Vaccine (2vHPV) Market Share by Application in 2022 & 2029
Figure 8. 9-16 Years Old
Figure 9. 16-20 Years Old
Figure 10. 20-26 Years Old
Figure 11. 26-45 Years Old
Figure 12. 2-valent HPV Vaccine (2vHPV) Report Years Considered
Figure 13. Global 2-valent HPV Vaccine (2vHPV) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global 2-valent HPV Vaccine (2vHPV) Revenue 2018-2029 (US$ Million)
Figure 15. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2018-2029)
Figure 17. Global 2-valent HPV Vaccine (2vHPV) Sales 2018-2029 ((K Units)
Figure 18. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2018-2029)
Figure 19. US & Canada 2-valent HPV Vaccine (2vHPV) Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe 2-valent HPV Vaccine (2vHPV) Sales YoY (2018-2029) & (K Units)
Figure 22. Europe 2-valent HPV Vaccine (2vHPV) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China 2-valent HPV Vaccine (2vHPV) Sales YoY (2018-2029) & (K Units)
Figure 24. China 2-valent HPV Vaccine (2vHPV) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) 2-valent HPV Vaccine (2vHPV) Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) 2-valent HPV Vaccine (2vHPV) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The 2-valent HPV Vaccine (2vHPV) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of 2-valent HPV Vaccine (2vHPV) in the World: Market Share by 2-valent HPV Vaccine (2vHPV) Revenue in 2022
Figure 31. Global 2-valent HPV Vaccine (2vHPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
Figure 33. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
Figure 34. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
Figure 35. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
Figure 37. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
Figure 39. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada 2-valent HPV Vaccine (2vHPV) Revenue Share by Country (2018-2029)
Figure 41. US & Canada 2-valent HPV Vaccine (2vHPV) Sales Share by Country (2018-2029)
Figure 42. U.S. 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 43. Canada 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 44. Europe 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
Figure 45. Europe 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
Figure 46. Europe 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
Figure 47. Europe 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
Figure 48. Europe 2-valent HPV Vaccine (2vHPV) Revenue Share by Country (2018-2029)
Figure 49. Europe 2-valent HPV Vaccine (2vHPV) Sales Share by Country (2018-2029)
Figure 50. Germany 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 51. France 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 53. Italy 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 54. Russia 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 55. China 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
Figure 56. China 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
Figure 57. China 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
Figure 58. China 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
Figure 59. Asia 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
Figure 60. Asia 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
Figure 61. Asia 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
Figure 62. Asia 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
Figure 63. Asia 2-valent HPV Vaccine (2vHPV) Revenue Share by Region (2018-2029)
Figure 64. Asia 2-valent HPV Vaccine (2vHPV) Sales Share by Region (2018-2029)
Figure 65. Japan 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 69. India 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America 2-valent HPV Vaccine (2vHPV) Sales Share by Country (2018-2029)
Figure 76. Brazil 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 79. Israel 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries 2-valent HPV Vaccine (2vHPV) Revenue (2018-2029) & (US$ Million)
Figure 81. 2-valent HPV Vaccine (2vHPV) Value Chain
Figure 82. 2-valent HPV Vaccine (2vHPV) Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed